Galderma S.A.

Industry

  • Digital Health
    • Disease Management
  • Pharmaceuticals
    • OTC, Consumer
    • Vaccines
    • Drug Delivery
      • Topical Delivery
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • ALASTIN Skincare
  • Alastin Skincare
  • CollaGenex Pharmaceuticals
  • Nestle
  • Nestle Skin Health S.A.
  • Nestlé Skin Health
  • Q-Med AB
  • Spirig Pharma AG.
See more in Biomedtracker

Latest on Galderma S.A.

Scrip

Finance Watch: Cargo Restructuring Not The News The IPO Market Needs

 
• By Mandy Jackson

Cargo Therapeutics’ decision to end all development for its allogeneic cell therapy technology platform and its cancer cell therapy candidates is not the kind of news the biopharmaceutical sector need

Scrip

Almirall Predicts Plenty More Growth In Psoriasis

 
• By Kevin Grogan

A decade ago, Almirall took the strategic decision to focus exclusively on medical dermatology, and after posting a strong set of financials for 2024, CEO Carlos Gallardo has told investors that “I’m

Scrip

Scrip Asks... What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances

 
• By Eleanor Malone

“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office

In Vivo

Financing Quarterly Statistics, Q4 2024

 
• By Deanna Kamienski and Maureen Riordan

Biopharma financing during the fourth quarter of 2024 totaled $16.8bn from 251 deals. Of those, 60 reached $100m or more. The follow-on public offering (FOPO) and venture financing categories tied for